Rang	Name	Position
1	Mr. Brian McKelligon	President, CEO & Director
2	Mr. John Frederick Ek CPA	CFO & Principal Accounting Officer
3	Dr. Niroshan Ramachandran Ph.D.	Chief Business Officer
4	Mr. Anthony Catalano	Senior Vice President of Operations
5	Mr. Priyam Shah	Senior Director of Business Development & Investor Relations Strategy
6	Ms. Jennifer Kamocsay	Chief Legal Officer
7	Dr. Pascal Bamford Ph.D.	Chief Clinical Officer
8	Mr. Rob C. Hart C.F.A., CFA, J.D.	Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Blue Water Life Science Advisors, LLC	9,40%	6,06 Mio. USD
2	BlackRock Inc	3,23%	2,08 Mio. USD
3	Vanguard Group Inc	2,39%	1,54 Mio. USD
4	PARAGON Assoc & PARAGON Assoc II JV	1,34%	0,87 Mio. USD
5	Geode Capital Management, LLC	1,14%	0,73 Mio. USD
6	State Street Corp	0,99%	0,64 Mio. USD
7	JPMorgan Chase & Co	0,82%	0,53 Mio. USD
8	Nuveen, LLC	0,79%	0,51 Mio. USD
9	UBS Group AG	0,56%	0,36 Mio. USD
10	Peddock Capital Advisors, LLC	0,47%	0,30 Mio. USD
11	Northern Trust Corp	0,46%	0,30 Mio. USD
12	ExodusPoint Capital Management, LP	0,41%	0,27 Mio. USD
13	Goldman Sachs Group Inc	0,35%	0,22 Mio. USD
14	JBF Capital, Inc.	0,24%	0,15 Mio. USD
15	Morgan Stanley - Brokerage Accounts	0,23%	0,15 Mio. USD
16	Millennium Management LLC	0,23%	0,15 Mio. USD
17	Virtu Financial LLC	0,20%	0,13 Mio. USD
18	Css LLC	0,19%	0,12 Mio. USD
19	Rhumbline Advisers	0,15%	0,10 Mio. USD
20	Marshall Wace Asset Management Ltd	0,15%	0,10 Mio. USD